Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
PRETOMANID
(2019)
Small molecule
Unknown
ORAL
Approved
Tuberculosis; Tuberculosis, Pulmonary
PRETOMANID
×
Maximum Phase:
4
First Approval:
2019
UNII:
2XOI31YC4N
Molecule Type:
Small molecule
Molecular Formula:
C14H12F3N3O5
Molecular Weight:
359.26
AlogP:
2.67
PSA:
88.65
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ALPELISIB
(2019)
Small molecule
PI3-kinase p110-alpha subunit inhibitor
ORAL
Approved
Breast Neoplasms; Neoplasms
ALPELISIB
×
Maximum Phase:
4
First Approval:
2019
UNII:
08W5N2C97Q
Molecule Type:
Small molecule
Molecular Formula:
C19H22F3N5O2S
Molecular Weight:
441.48
AlogP:
3.84
PSA:
101.21
HBD:
2.0
HBA:
#RotB:
4.0
Source:
TRIFAROTENE
(2019)
Small molecule
Retinoic acid receptor gamma agonist
TOPICAL
Approved
Acne Vulgaris
TRIFAROTENE
×
Maximum Phase:
4
First Approval:
2019
UNII:
0J8RN2W0HK
Molecule Type:
Small molecule
Molecular Formula:
C29H33NO4
Molecular Weight:
459.59
AlogP:
5.99
PSA:
70.0
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ERDAFITINIB
(2019)
Small molecule
Fibroblast growth factor receptor inhibitor
ORAL
Approved
Carcinoma, Transitional Cell; Neoplasms; Urinary Bladder Neoplasms
ERDAFITINIB
×
Maximum Phase:
4
First Approval:
2019
UNII:
890E37NHMV
Molecule Type:
Small molecule
Molecular Formula:
C25H30N6O2
Molecular Weight:
446.56
AlogP:
4.18
PSA:
77.33
HBD:
1.0
HBA:
#RotB:
9.0
Source:
ELEXACAFTOR
(2019)
Small molecule
Cystic fibrosis transmembrane conductance regulator positive modulator
Unknown
Approved
Unknown
ELEXACAFTOR
×
Maximum Phase:
4
First Approval:
2019
UNII:
RRN67GMB0V
Molecule Type:
Small molecule
Molecular Formula:
C26H34F3N7O4S
Molecular Weight:
597.66
AlogP:
4.02
PSA:
124.24
HBD:
1.0
HBA:
#RotB:
8.0
Source:
TRICLABENDAZOLE
(2019)
Small molecule
Unknown
ORAL
Approved
Fascioliasis; Helminthiasis
TRICLABENDAZOLE
×
Maximum Phase:
4
First Approval:
2019
UNII:
4784C8E03O
Molecule Type:
Small molecule
Molecular Formula:
C14H9Cl3N2OS
Molecular Weight:
359.67
AlogP:
6.04
PSA:
37.91
HBD:
1.0
HBA:
#RotB:
3.0
Source:
RELEBACTAM
(2019)
Small molecule
Bacterial beta-lactamase TEM inhibitor
Unknown
Approved
Intraabdominal Infections; Pyelonephritis; Urinary Tract Infections
RELEBACTAM
×
Maximum Phase:
4
First Approval:
2019
UNII:
1OQF7TT3PF
Molecule Type:
Small molecule
Molecular Formula:
C12H20N4O6S
Molecular Weight:
348.38
AlogP:
-1.14
PSA:
128.28
HBD:
3.0
HBA:
#RotB:
4.0
Source:
ENTRECTINIB
(2019)
Small molecule
ALK tyrosine kinase receptor inhibitor
ORAL
Approved
Carcinoma, Non-Small-Cell Lung; Neoplasms
ENTRECTINIB
×
Maximum Phase:
4
First Approval:
2019
UNII:
L5ORF0AN1I
Molecule Type:
Small molecule
Molecular Formula:
C31H34F2N6O2
Molecular Weight:
560.65
AlogP:
5.03
PSA:
85.52
HBD:
3.0
HBA:
#RotB:
7.0
Source:
DAROLUTAMIDE
(2019)
Small molecule
Androgen Receptor antagonist
ORAL
Approved
Neoplasms; Prostatic Neoplasms
DAROLUTAMIDE
×
Maximum Phase:
4
First Approval:
2019
UNII:
X05U0N2RCO
Molecule Type:
Small molecule
Molecular Formula:
C19H19ClN6O2
Molecular Weight:
398.85
AlogP:
2.67
PSA:
119.62
HBD:
3.0
HBA:
#RotB:
6.0
Source:
UPADACITINIB
(2019)
Small molecule
Janus Kinase (JAK) inhibitor
ORAL
Approved
Arthritis, Rheumatoid; Immune System Diseases
UPADACITINIB
×
Maximum Phase:
4
First Approval:
2019
UNII:
4RA0KN46E0
Molecule Type:
Small molecule
Molecular Formula:
C17H19F3N6O
Molecular Weight:
380.37
AlogP:
2.91
PSA:
78.32
HBD:
2.0
HBA:
#RotB:
3.0
Source:
LUMATEPERONE
(2019)
Small molecule
Dopamine D2 receptor antagonist
Unknown
Approved
Psychotic Disorders
LUMATEPERONE
×
Maximum Phase:
4
First Approval:
2019
UNII:
70BSQ12069
Molecule Type:
Small molecule
Molecular Formula:
C24H28FN3O
Molecular Weight:
393.51
AlogP:
3.92
PSA:
26.79
HBD:
0.0
HBA:
#RotB:
5.0
Source:
PEXIDARTINIB HYDROCHLORIDE
(2019)
Small molecule
Macrophage colony stimulating factor receptor inhibitor
ORAL
Approved
Giant Cell Tumor of Tendon Sheath
PEXIDARTINIB HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2019
UNII:
YS6WAI3XN7
Molecule Type:
Small molecule
Molecular Formula:
C20H16Cl2F3N5
Molecular Weight:
454.28
AlogP:
5.23
PSA:
66.49
HBD:
2.0
HBA:
#RotB:
5.0
Source:
AMLODIPINE BENZOATE
(2019)
Small molecule
Voltage-gated L-type calcium channel blocker
ORAL
Approved
Coronary Artery Disease; Diabetes Mellitus; Heart Failure; Hypertension; Myocardial Infarction; Stroke
AMLODIPINE BENZOATE
×
Maximum Phase:
4
First Approval:
2019
UNII:
XD75TQ8A2P
Molecule Type:
Small molecule
Molecular Formula:
C27H31ClN2O7
Molecular Weight:
531.01
AlogP:
2.27
PSA:
99.88
HBD:
2.0
HBA:
#RotB:
8.0
Source:
SOLRIAMFETOL
(2019)
Small molecule
Unknown
ORAL
Approved
Attention Deficit Disorder with Hyperactivity
SOLRIAMFETOL
×
Maximum Phase:
4
First Approval:
2019
UNII:
939U7C91AI
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O2
Molecular Weight:
194.23
AlogP:
0.65
PSA:
78.34
HBD:
2.0
HBA:
#RotB:
4.0
Source:
FLUORODOPA
(2019)
Small molecule
Unknown
Unknown
Approved
Unknown
FLUORODOPA
×
Maximum Phase:
4
First Approval:
2019
UNII:
6WIZ27OUZ9
Molecule Type:
Small molecule
Molecular Formula:
C9H10FNO4
Molecular Weight:
215.18
AlogP:
0.19
PSA:
103.78
HBD:
4.0
HBA:
#RotB:
3.0
Source:
LUMATEPERONE TOSYLATE
(2019)
Small molecule
Unknown
Unknown
Approved
Schizophrenia
LUMATEPERONE TOSYLATE
×
Maximum Phase:
4
First Approval:
2019
UNII:
JIE88N006O
Molecule Type:
Small molecule
Molecular Formula:
C31H36FN3O4S
Molecular Weight:
565.71
AlogP:
3.92
PSA:
26.79
HBD:
0.0
HBA:
#RotB:
5.0
Source:
FEDRATINIB HYDROCHLORIDE
(2019)
Small molecule
Tyrosine-protein kinase JAK2 inhibitor
ORAL
Approved
Primary Myelofibrosis
FEDRATINIB HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2019
UNII:
UH9J2HBQWJ
Molecule Type:
Small molecule
Molecular Formula:
C27H40Cl2N6O4S
Molecular Weight:
615.63
AlogP:
4.82
PSA:
108.48
HBD:
3.0
HBA:
#RotB:
10.0
Source:
SELENIOUS ACID
(2019)
Small molecule
Supplement
INTRAVENOUS
Approved
Unknown
SELENIOUS ACID
×
Maximum Phase:
4
First Approval:
2019
UNII:
F6A27P4Q4R
Molecule Type:
Small molecule
Molecular Formula:
H2O3Se
Molecular Weight:
128.97
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LEFAMULIN
(2019)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
LEFAMULIN
×
Maximum Phase:
4
First Approval:
2019
UNII:
21904A5386
Molecule Type:
Small molecule
Molecular Formula:
C28H45NO5S
Molecular Weight:
507.74
AlogP:
3.87
PSA:
109.85
HBD:
3.0
HBA:
#RotB:
5.0
Source:
TENAPANOR HYDROCHLORIDE
(2019)
Small molecule
Sodium/hydrogen exchanger 3 inhibitor
ORAL
Approved
Constipation; Irritable Bowel Syndrome
TENAPANOR HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2019
UNII:
50605O2ZNS
Molecule Type:
Small molecule
Molecular Formula:
C50H68Cl6N8O10S2
Molecular Weight:
1217.99
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FEDRATINIB
(2019)
Small molecule
Tyrosine-protein kinase JAK2 inhibitor
Unknown
Approved
Neoplasms
FEDRATINIB
×
Maximum Phase:
4
First Approval:
2019
UNII:
6L1XP550I6
Molecule Type:
Small molecule
Molecular Formula:
C27H36N6O3S
Molecular Weight:
524.69
AlogP:
4.82
PSA:
108.48
HBD:
3.0
HBA:
#RotB:
10.0
Source:
TENAPANOR
(2019)
Small molecule
Unknown
Unknown
Approved
Constipation
TENAPANOR
×
Maximum Phase:
4
First Approval:
2019
UNII:
WYD79216A6
Molecule Type:
Small molecule
Molecular Formula:
C50H66Cl4N8O10S2
Molecular Weight:
1145.07
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CEFIDEROCOL
(2019)
Small molecule
Bacterial penicillin-binding protein inhibitor
Unknown
Approved
Bacterial Infections
CEFIDEROCOL
×
Maximum Phase:
4
First Approval:
2019
UNII:
SZ34OMG6E8
Molecule Type:
Small molecule
Molecular Formula:
C30H34ClN7O10S2
Molecular Weight:
752.23
AlogP:
-0.18
PSA:
256.9
HBD:
6.0
HBA:
#RotB:
13.0
Source:
BREXANOLONE
(2019)
Small molecule
GABA-A receptor; anion channel positive allosteric modulator
INTRAVENOUS
Approved
Depression, Postpartum
BREXANOLONE
×
Maximum Phase:
4
First Approval:
2019
UNII:
S39XZ5QV8Y
Molecule Type:
Small molecule
Molecular Formula:
C21H34O2
Molecular Weight:
318.5
AlogP:
4.6
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
PSMA-HBED-CC
(2020)
Small molecule
Unknown
Unknown
Investigational
Unknown
PSMA-HBED-CC
×
Maximum Phase:
4
First Approval:
2020
UNII:
9AG41L3AOQ
Molecule Type:
Small molecule
Molecular Formula:
C44H59GaN6O17
Molecular Weight:
1013.7
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
OSILODROSTAT PHOSPHATE
(2020)
Small molecule
Cytochrome P450 11B1 inhibitor
Unknown
Approved
Pituitary ACTH Hypersecretion
OSILODROSTAT PHOSPHATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
Y6581YAW9V
Molecule Type:
Small molecule
Molecular Formula:
C13H13FN3O4P
Molecular Weight:
325.24
AlogP:
2.43
PSA:
41.61
HBD:
0.0
HBA:
#RotB:
1.0
Source:
SELUMETINIB SULFATE
(2020)
Small molecule
Dual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor
Unknown
Approved
Neurofibromatoses; Neurofibromatosis 1
SELUMETINIB SULFATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
807ME4B7IJ
Molecule Type:
Small molecule
Molecular Formula:
C17H17BrClFN4O7S
Molecular Weight:
555.77
AlogP:
3.53
PSA:
88.41
HBD:
3.0
HBA:
#RotB:
6.0
Source:
MAGNESIUM OXYBATE
(2020)
Small molecule
GABA-B receptor agonist
Unknown
Approved
Unknown
MAGNESIUM OXYBATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
G983HLV265
Molecule Type:
Small molecule
Molecular Formula:
C8H14MgO6
Molecular Weight:
230.5
AlogP:
-0.16
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
3.0
Source:
LASMIDITAN
(2020)
Small molecule
Serotonin 1f (5-HT1f) receptor agonist
ORAL
Approved
Migraine Disorders
LASMIDITAN
×
Maximum Phase:
4
First Approval:
2020
UNII:
760I9WM792
Molecule Type:
Small molecule
Molecular Formula:
C19H18F3N3O2
Molecular Weight:
377.37
AlogP:
3.28
PSA:
62.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
OSILODROSTAT
(2020)
Small molecule
Unknown
Unknown
Approved
Adrenal Gland Diseases
OSILODROSTAT
×
Maximum Phase:
4
First Approval:
2020
UNII:
5YL4IQ1078
Molecule Type:
Small molecule
Molecular Formula:
C13H10FN3
Molecular Weight:
227.24
AlogP:
2.43
PSA:
41.61
HBD:
0.0
HBA:
#RotB:
1.0
Source:
REMIMAZOLAM
(2020)
Small molecule
Unknown
Unknown
Approved
Unknown
REMIMAZOLAM
×
Maximum Phase:
4
First Approval:
2020
UNII:
7V4A8U16MB
Molecule Type:
Small molecule
Molecular Formula:
C21H19BrN4O2
Molecular Weight:
439.31
AlogP:
4.18
PSA:
69.37
HBD:
0.0
HBA:
#RotB:
4.0
Source:
CALCIUM OXYBATE
(2020)
Small molecule
GABA-B receptor agonist
Unknown
Approved
Unknown
CALCIUM OXYBATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
8W24SYD6ZI
Molecule Type:
Small molecule
Molecular Formula:
C8H14CaO6
Molecular Weight:
246.27
AlogP:
-0.16
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
3.0
Source:
SELPERCATINIB
(2020)
Small molecule
Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RET inhibitor
Unknown
Approved
Carcinoma, Medullary; Carcinoma, Non-Small-Cell Lung; Neoplasms; Thyroid Neoplasms
SELPERCATINIB
×
Maximum Phase:
4
First Approval:
2020
UNII:
CEGM9YBNGD
Molecule Type:
Small molecule
Molecular Formula:
C29H31N7O3
Molecular Weight:
525.61
AlogP:
3.28
PSA:
112.04
HBD:
1.0
HBA:
#RotB:
8.0
Source:
NIFURTIMOX
(2020)
Small molecule
DNA inhibitor
Unknown
Approved
Chagas Disease; Leishmaniasis; Trypanosomiasis
NIFURTIMOX
×
Maximum Phase:
4
First Approval:
2020
UNII:
M84I3K7C2O
Molecule Type:
Small molecule
Molecular Formula:
C10H13N3O5S
Molecular Weight:
287.3
AlogP:
0.64
PSA:
106.02
HBD:
0.0
HBA:
#RotB:
3.0
Source:
RISDIPLAM
(2020)
Small molecule
SMN2 pre-mRNA positive modulator
Unknown
Approved
Atrophy; Muscular Atrophy, Spinal
RISDIPLAM
×
Maximum Phase:
4
First Approval:
2020
UNII:
76RS4S2ET1
Molecule Type:
Small molecule
Molecular Formula:
C22H23N7O
Molecular Weight:
401.47
AlogP:
1.96
PSA:
79.83
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CLASCOTERONE
(2020)
Small molecule
Androgen Receptor antagonist
Unknown
Approved
Acne Vulgaris
CLASCOTERONE
×
Maximum Phase:
4
First Approval:
2020
UNII:
XN7MM8XG2M
Molecule Type:
Small molecule
Molecular Formula:
C24H34O5
Molecular Weight:
402.53
AlogP:
3.77
PSA:
80.67
HBD:
1.0
HBA:
#RotB:
4.0
Source:
1
2
…
70
71
72
73
74
75
76
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA